CoChat

Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer

Open access
Yang, Hao, Zou, Xiaoming, Yang, Shifeng, Zhang, Ange, Li, Nana, Ma, Zhen · 2023 · Frontiers in Immunology

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Background: The epigenetic regulatory chemical lactate is a product of glycolysis. It can regulate gene expression through histone lactylation, thereby promoting tumor proliferation, metastasis, and immunosuppression. Methods: In this study, a lactylation-related model for gastric cancer (GC) was constructed, and its relationships to prognosis, immune cell infiltration, and immunotherapy were investigated. By contrasting normal tissues and tumor tissues, four lactylation-related pathways that were substantially expressed in GC tissues were found in the GSEA database. Six lactylation-related genes were screened for bioinformatic analysis. The GC data sets from the TCGA and GEO databases were downloaded and integrated to perform cluster analysis, and the lactylation related model was constructed by secondary clustering. Results: The fingding demonstrated that the lactylation score has a strong correlation with the overall survival rate from GC and the progression of GC. Mechanistic experiments showed that abundant immune cell infiltration (macrophages showed the highest degree of infiltration) and increased genetic instability are traits of high lactylation scores. Immune checkpoint inhibitors (ICIs) demonstrated a reduced response rate in GC with high lactylation scores. At the same time, tumors with high lactylation scores had high Tumor Immune Dysfunction and Exclusion scores, which means that they had a higher risk of immune evasion and dysfunction. Discussion: These findings indicate that the lactylation score can be used to predict the malignant progression and immune evasion of GC. This model also can guide the treatment response to ICIs of GC. The constructed model of the lactate gene is also expected to become a potential therapeutic target for GC and diagnostic marker.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2023.1149989

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart of the study.
Figure 1 Flowchart of the study.CC BY · PubMed Central
Figure 2 Expression of lactylation-related genes in GC. (A) Highly expressed GSEA pathway in GC tissues. (B) Univariate Cox analysis of lactylation-related genes. (C) Expression of lactylation-related genes in GC tissues and normal gastric tissues. ***p<0.001. (D) Diagram of the copy number frequencies of lactylation-related genes. (E) Waterfall plot of the mutation frequencies of lactylation-related genes. (F) Circle plot of the copy numbers of lactylation-related genes. (G) Overall survival rate of lactylation-related gene patient groups. (H) Prognostic network of lactylation-related genes.
Figure 2 Expression of lactylation-related genes in GC. (A) Highly expressed GSEA pathway in GC tissues. (B) Univariate Cox analysis of lactylation-related genes. (C) Expression of lactylation-related genes in GC tissues and normal gastric tissues. ***p<0.001. (D) Diagram of the copy number frequencies of lactylation-related genes. (E) Waterfall plot of the mutation frequencies of lactylation-related genes. (F) Circle plot of the copy numbers of lactylation-related genes. (G) Overall survival rate of lactylation-related gene patient groups. (H) Prognostic network of lactylation-related genes.CC BY · PubMed Central
Figure 3 GC classification of lactylation-related genes. (A) Changes in the length and inclination of the cumulative distribution function (CDF) curve when k=2-9. (B) Area under the CDF curve when k=2-9. (C) GC samples were divided into two tumor clusters. (D) Kaplan–Meier survival curves of the two clusters. (E) Immune cell infiltration of the two clusters. *p<0.05; **p<0.01; ***p<0.001; ns, no signifificance. (F) Heatmap of GC classification, lactylation-related genes, and clinicopathological characteristics. (G) GO enrichment analysis of the two GC clusters. (H) KEGG enrichment analysis of the two clusters.
Figure 3 GC classification of lactylation-related genes. (A) Changes in the length and inclination of the cumulative distribution function (CDF) curve when k=2-9. (B) Area under the CDF curve when k=2-9. (C) GC samples were divided into two tumor clusters. (D) Kaplan–Meier survival curves of the two clusters. (E) Immune cell infiltration of the two clusters. *p<0.05; **p<0.01; ***p<0.001; ns, no signifificance. (F) Heatmap of GC classification, lactylation-related genes, and clinicopathological characteristics. (G) GO enrichment analysis of the two GC clusters. (H) KEGG enrichment analysis of the two clusters.CC BY · PubMed Central
Figure 4 lactylation score model. (A) PCA of lactylation-related genes. (B) Lactylation scores of GC types. (C) Kaplan–Meier survival curve of the high- and low-lactylation-score groups. (D) Spearman correlation analysis of the lactylation score and immune cells. (E) UBQLN4 expression in the high- and low-lactylation-score groups. (F) Sankey plot of GC clusters, lactylation score, and patient survival. (G) Waterfall plot of mutation frequencies in the low-lactylation-score group. (H) Waterfall plot of mutation frequencies in the high-lactylation-score group. (I) Kaplan–Meier survival curve of the high-tumor-mutation-burden group and the low-tumor-mutation-burden group. (J) Joint survival analysis was performed in the high and low-tumor-mutation-burden groups and the high- and low-lactylation-score groups. (K) The age, sex, survival, grade, T stage, and N stage of patients in the high- and low-lactylation-score groups. (L) Nomogram of the lactylation score and clinical information. ***p<0.001 (M) AUC of the lactylation score model.
Figure 4 lactylation score model. (A) PCA of lactylation-related genes. (B) Lactylation scores of GC types. (C) Kaplan–Meier survival curve of the high- and low-lactylation-score groups. (D) Spearman correlation analysis of the lactylation score and immune cells. (E) UBQLN4 expression in the high- and low-lactylation-score groups. (F) Sankey plot of GC clusters, lactylation score, and patient survival. (G) Waterfall plot of mutation frequencies in the low-lactylation-score group. (H) Waterfall plot of mutation frequencies in the high-lactylation-score group. (I) Kaplan–Meier survival curve of the high-tumor-mutation-burden group and the low-tumor-mutation-burden group. (J) Joint survival analysis was performed in the high and low-tumor-mutation-burden groups and the high- and low-lactylation-score groups. (K) The age, sex, survival, grade, T stage, and N stage of patients in the high- and low-lactylation-score groups. (L) Nomogram of the lactylation score and clinical information. ***p<0.001 (M) AUC of the lactylation score model.CC BY · PubMed Central
Figure 5 Immune cells infiltration and function enrichment analysis. *p<0.05; **p<0.01; ***p<0.001. (A, B) The correlation between lactylation score and immune cell infiltration by various immunocytes analysis methods. (C) Correlation between lactylation score and the tumor microenvironment of gastric cancer assessed using the ESTIMATE algorithm. (D, E) GSVA analysis of lactylation score and lactylation-related genes.
Figure 5 Immune cells infiltration and function enrichment analysis. *p<0.05; **p<0.01; ***p<0.001. (A, B) The correlation between lactylation score and immune cell infiltration by various immunocytes analysis methods. (C) Correlation between lactylation score and the tumor microenvironment of gastric cancer assessed using the ESTIMATE algorithm. (D, E) GSVA analysis of lactylation score and lactylation-related genes.CC BY · PubMed Central
Figure 6 ICIs and immune evasion. *p<0.05; ***p<0.001. (A) Sensitivity analysis of the high- and low-lactylation-score groups to immunotherapy. (B) TIDE score, Dysfunction score, and Exclusion score of the high- and low-lactylation-score groups. (C, D) Microsatellite instability in the high- and low-lactylation-score groups. (E) Correlations between the lactylation score and lactylation-related gene expression. (F) PPI network between lactylation-related proteins and lactylation target genes. (G) Correlation between GLUT3 and lactylation-related genes. (H) GLUT3 expression in the high- and low-lactylation-score groups.
Figure 6 ICIs and immune evasion. *p<0.05; ***p<0.001. (A) Sensitivity analysis of the high- and low-lactylation-score groups to immunotherapy. (B) TIDE score, Dysfunction score, and Exclusion score of the high- and low-lactylation-score groups. (C, D) Microsatellite instability in the high- and low-lactylation-score groups. (E) Correlations between the lactylation score and lactylation-related gene expression. (F) PPI network between lactylation-related proteins and lactylation target genes. (G) Correlation between GLUT3 and lactylation-related genes. (H) GLUT3 expression in the high- and low-lactylation-score groups.CC BY · PubMed Central
Figure 7 Expression of PLOD2 and GLUT3 in GC cell lines and GC tissues. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. (A) Immunohistochemistry for PLOD2 and GLUT3 in normal gastric tissues and GC tissues. Scale bar, 100 µm. (B) Western blots for PLOD2 and GLUT3. (C) PCR results of PLOD2 and GLUT3. (D) Western blots of HGC cells treated with different concentrations of lactate dehydrogenase inhibitors (0.25 µM, 0.5 µM, and 1 µM). (E) Western blots after transfection with the PLOD2-KD plasmid. (F) Expression levels of GLUT3 and L-Lactyl in PLOD-NC group and PLOD-KD group were compared by immunofluorescence. Scale bar, 200 µm.
Figure 7 Expression of PLOD2 and GLUT3 in GC cell lines and GC tissues. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. (A) Immunohistochemistry for PLOD2 and GLUT3 in normal gastric tissues and GC tissues. Scale bar, 100 µm. (B) Western blots for PLOD2 and GLUT3. (C) PCR results of PLOD2 and GLUT3. (D) Western blots of HGC cells treated with different concentrations of lactate dehydrogenase inhibitors (0.25 µM, 0.5 µM, and 1 µM). (E) Western blots after transfection with the PLOD2-KD plasmid. (F) Expression levels of GLUT3 and L-Lactyl in PLOD-NC group and PLOD-KD group were compared by immunofluorescence. Scale bar, 200 µm.CC BY · PubMed Central
Figure 8 Vitro assay results of PLOD2 in gastric cancer cell.*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. Scale bar, 200 µm. (A) Plate cloning assay results of PLOD2-NC and PLOD2-KD in HGC-27 and MKN-45 cells. (B) EdU assay results of PLOD2-NC and PLOD2-KD in HGC-27 and MKN-45 cells. (C) Wound-healing assay results of PLOD2-NC and PLOD2-KD in HGC-27 cells. (D) Transwell assay results of PLOD2-WT and PLOD2-KD in HGC-27 and MKN-45 cells.
Figure 8 Vitro assay results of PLOD2 in gastric cancer cell.*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. Scale bar, 200 µm. (A) Plate cloning assay results of PLOD2-NC and PLOD2-KD in HGC-27 and MKN-45 cells. (B) EdU assay results of PLOD2-NC and PLOD2-KD in HGC-27 and MKN-45 cells. (C) Wound-healing assay results of PLOD2-NC and PLOD2-KD in HGC-27 cells. (D) Transwell assay results of PLOD2-WT and PLOD2-KD in HGC-27 and MKN-45 cells.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 56 references

Cited by

See all 164

Metadata

Authors
Yang, H., Zou, X., Yang, S., Zhang, A., Li, N., & Ma, Z.
Affiliations
Harbin Medical University (CN)
Corresponding author
Zou, Xiaoming
Venue
Frontiers in Immunology
Published
2023-03-03
Volume
14
Pages
1149989-1149989
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4323045532
Cited by
139
References
56
Citations by year
2026: 33 · 2025: 68 · 2024: 32 · 2023: 6
FWCI
17.08
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
gastric cancer, histone lactylation, lactate, prognostic model, tumor immune cell infiltration, immune checkpoint inhibitors, immunotherapy response, tumor immune dysfunction and exclusion, immune evasion, macrophage infiltration, genomic instability, glycolysis, therapeutic target, diagnostic biomarkers
MeSH terms
Humans, Immunosuppression Therapy, Immunotherapy, Prognosis, Stomach Neoplasms, Cluster Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer. https://app.cochat.ai/papers/10.3389/fimmu.2023.1149989
The paper
Yang, H., Zou, X., Yang, S., Zhang, A., Li, N., & Ma, Z. (2023). Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1149989

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.